Evaluation of antibiotic synergy against Acinetobacter baumannii: A comparison with Etest, time-kill, and checkerboard methods

Diagnostic Microbiology and Infectious Disease

Volumn 38, Issue 1, 2000, Pages 43-50

  Bonapace, Charles R ^a   White, Roger L ^a   Friedrich, Lawrence V ^a   Bosso, John A ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFEPIME; PIPERACILLIN; TOBRAMYCIN; TROVAFLOXACIN;

ACCURACY; ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERICIDAL ACTIVITY; BACTERIUM ISOLATE; CONTROLLED STUDY; DEVICE; DRUG POTENTIATION; INTERMETHOD COMPARISON; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; VALIDATION PROCESS;

ACINETOBACTER; ACINETOBACTER INFECTIONS; ANTI-INFECTIVE AGENTS, FLUOROQUINOLONE; ANTIBIOTICS, AMINOGLYCOSIDE; ANTIBIOTICS, COMBINED; CEPHALOSPORINS; COMPARATIVE STUDY; DRUG SYNERGISM; HUMAN; MICROBIAL SENSITIVITY TESTS; NAPHTHYRIDINES; PENICILLINS; PIPERACILLIN; REPRODUCIBILITY OF RESULTS; SUPPORT, NON-U.S. GOV'T; TOBRAMYCIN;

EID: 0033802358     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0732-8893(00)00163-2     Document Type: Article

References (19)

1. Afzal-Shah, M., & Livermore D. M. (1998). Worldwide emergence of carbapenem-resistant Acinetobacter spp. J Antimicrob Chemother, 41, 576-577.
2. Bajaksouzian S., et al. Activities of levofloxacin, ofloxacin, and ciprofloxacin, alone and in combination with amikacin, against Acinetobacters as determined by checkerboard and time-kill studies. Antimicrob Agents Chemother. 41:1997;1073-1076.
3. Bergogne-Bérézin E., et al. Epidemiology of nosocomial infections due to Acinetobacter calcoaceticus. J Hosp Infect. 10:1987;105-113.
4. Bergogne-Bérézin E., Joly-Guillou M.L. Hospital infection with Acinetobacter spp. an increasing problem . J Hosp Infect. 18:(Suppl A):1991;250-255.
5. Bergogne-Bérézin E., Towner K.J. Acinetobacter spp. as nosocomial pathogens microbiological, clinical, and epidemiological features . Clin Microbiol Rev. 9:1996;148-165.
6. Bouvet, P. J. M., & Grimont P. A. D. (1987). Identification and biotyping of clinical isolates of. Acinetobacter Ann Inst Pasteur Microbiol, 138, 569-578.
7. Cappelletty D.M., Rybak M.J. Comparison of methodologies for synergism testing of drug combinations against resistant strains of Pseudomonas aeruginosa. Antimicrob Agents Chemother. 40:1996;677-683.
8. Chow A.W., et al. Synergistic interactions of ciprofloxacin and extended spectrum β-lactams or aminoglycosides against Acinetobacter calcoaceticus ss. anitratus. Diagn Microbiol Infect Dis. 9:1988;213-217.
9. Eliopoulos, G. M., & Moellering, R. C. (1996). Antimicrobial combinations. In Antibiotics in Laboratory Medicine 4th ed, Ed V. Lorian. Baltimore: Williams & Wilkins, pp. 330-396.
10. Glew R.H., et al. In vitro synergism between carbenicillin and aminoglycosidic aminocyclitols against Acinetobacter calcoaceticus var. anitratus. Antimicrob Agents Chemother. 6:1977;1036-1041.
11. Martinez-Martinez L., et al. In-vitro activity of antimicrobial agent combinations against multiresistant Acinetobacter baumannii. J Antimicrob Chemother. 38:1996;1107-1108.
12. National Committee for Clinical Laboratory Standards. (1993). Methods for dilution antimicroibal susceptibility tests for bacteria that grow aerobically: NCCLS Document M7-A3, Vol. 13, No. 25 National Committee for Clinical Laboratory Standards, Villanova, PA.
13. National Committee for Clinical Laboratory Standards. (1999). Performance standards for antimicrobial susceptibililty testing: NCCLS Document M100-S9, Vol. 19, No. 1 National Committee for Clinical Laboratory Standards, Wayne, PA.
14. Ng P.C., et al. An outbreak of Acinetobacter septicaemia in a neonatal intensive care unit. J Hosp Infect. 14:1989;363-368.
15. Pascual A. In-vitro susceptibilies of multiresistant strains of Acinetobacter baumannii to eight quinolones. J Antimicrob Chemother. 40:1997;140-142.
16. Pfizer, Inc. Trovan package insert. New York, NY; December 1998.
17. Tankovic J., et al. Characterization of a hospital outbreak of imipenem-resistant Acinetobacter baumannii by phenotypic and genotypic typing methods. J Clin Microbiol. 32:1994;2677-2681.
18. Weinbren M.J., et al. Acinetobacter spp. isolates with reduced susceptibilities to carbapenems in a UK burns unit. J Antimicrob Chemother. 41:1998;574-576.
19. White R.L., et al. Comparison of three different in vitro methods of detecting synergy Time-kill, checkerboard, and Etest . Antimicrob Agents Chemother. 40:1996;1914-1918.